To better understand changes in the private plans providing drug coverage to Medicare beneficiaries under the program's Part D benefit, the Kaiser Family Foundation is issuing a series of data spotlights analyzing key elements of Medicare's private drug plans. Each spotlight will focus on a key aspect of the drug plans that will be available to Medicare beneficiaries in 2008 and examine relevant trends since the Medicare drug benefit took effect in 2006.

>>More Recent Medicare Part D Data Spotlights Now Available

These spotlights were prepared by a team of researchers at Georgetown University, NORC and the Kaiser Family Foundation.

Medicare Prescription Drug Plans in 2008 And Key Changes Since 2006: Summary Of Findings

Medicare Part D 2008 Data Spotlight: Ten Most Common Brand-Name Drugs

Medicare Part D 2008 Data Spotlight: Low-Income Subsidy Plan Availability

Medicare Part D 2008 Data Spotlight: Utilization Management

Medicare Part D 2008 Data Spotlight: Formularies

Medicare Part D 2008 Data Spotlight: Specialty Tiers

Medicare Part D 2008 Data Spotlight: Benefit Design

Medicare Part D 2008 Data Spotlight: Premiums

Medicare Part D 2008 Data Spotlight: The Coverage Gap

Appendix with Methodology

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.